Loading
A phase 3 trial in lung cancer, run by Hunan Cancer Hospital, now recruiting.
Immunonutrition Reduces Acute Esophagitis After Thoracic Radiotherapy in Lung Cancer is a phase 3, randomised interventional study registered as NCT06840704 by Hunan Cancer Hospital, with a registry enrolment figure of 121 participants, started 2025-02-25 and due to reach its primary completion in 2026-06-30. Interventions recorded: Oral immunonutrition. Conditions listed: Non Small Cell Lung Cancer; Small Cell Lung Cancer. Primary outcome: Incidence rate of grade 2 or higher acute esophagitis. Lung eligibility wording from the registry: "Pathologically confirmed diagnosis of lung cancer, including non-small cell lung cancer and small cell lung cancer". Sites: China. No results are recorded here; the registry entry is the source.
Shares Lung cancer trials open today (registry snapshot), IMRT / IGRT (modern external beam), Non-small-cell lung cancer and the tag lung-deep-dive.
Shares Lung cancer trials open today (registry snapshot), IMRT / IGRT (modern external beam), Non-small-cell lung cancer and the tag lung-deep-dive.
Shares Lung cancer trials open today (registry snapshot), IMRT / IGRT (modern external beam), Non-small-cell lung cancer and the tag lung-deep-dive.
Shares Lung cancer trials open today (registry snapshot), IMRT / IGRT (modern external beam), Non-small-cell lung cancer and the tag lung-deep-dive.
Shares Lung cancer trials open today (registry snapshot), IMRT / IGRT (modern external beam), Non-small-cell lung cancer and the tag lung-deep-dive.
Shares Lung cancer trials open today (registry snapshot), IMRT / IGRT (modern external beam), Non-small-cell lung cancer and the tag lung-deep-dive.
Shares Lung cancer trials open today (registry snapshot), Non-small-cell lung cancer and the tag lung-deep-dive.
Shares Lung cancer trials open today (registry snapshot), Non-small-cell lung cancer and the tag lung-deep-dive.